Clinical trials
Adult clinical trials
Below are recruiting adult clinical trials, each written for real people, not researchers. We’re tracking 3,745 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07553312Enrolling by invitation
Community Support Program for Women Living With HIV
This study tests whether connecting women with HIV/AIDS between their hospital clinic and community resources improves their health and well-being. The program aims to bridge the gap between medical care and community support to help you stay healthier.
Baltimore, MarylandAges 18 years+ - NCT07557550Recruiting
Relaxation methods before orthopedic surgery: glasses vs. virtual reality
This study tests whether watching relaxing videos through special glasses or a virtual reality headset helps reduce anxiety before orthopedic surgery (like hip or knee replacement). Researchers want to see if these tools work better than no relaxation aid at all.
Amiens, PicardieAges 18 years+ - NCT07551960Enrolling by invitation
Testing a Health Risk Prevention Platform for Adults
This study tests a digital platform called STELA that helps adults reduce their risk of heart disease and stroke by identifying and managing modifiable health factors like diet, exercise, and stress. You'll complete health assessments online to see if this preventive approach works.
Třinec, Moravian-Silesian RegionAges 18–80 - NCT07551583RecruitingPhase 2
Nivolumab plus chemotherapy for early-stage Hodgkin lymphoma in young people
This study tests a combination of a newer immunotherapy drug (nivolumab) with standard chemotherapy (AVD) in children, teens, and young adults with newly diagnosed, early-stage Hodgkin lymphoma—a blood cancer affecting lymph nodes. The goal is to see if adding immunotherapy improves outcomes while being tolerable for this age group.
Houston, TexasAges 2–21 - NCT07553637RecruitingPhase 2
ALTO-207 for Adults With Hard-to-Treat Depression
This study tests whether a new medication called ALTO-207 can help people with depression that hasn't improved with standard antidepressants. You may qualify if you've tried multiple antidepressants without enough relief and are willing to add this experimental treatment to your current medication.
Birmingham, AlabamaAges 18–75 - NCT07559175RecruitingPhase 2
A new enzyme treatment for pancreatic insufficiency
This study tests a new pancreatic enzyme medicine (called NHS7108) for people with exocrine pancreatic insufficiency (EPI). EPI means your pancreas doesn't make enough enzymes to break down food properly. The study aims to see if this new medicine is safe and works well to help your body absorb nutrients.
Scottsdale, ArizonaAges 18–85 - NCT07553442RecruitingPhase 2
Testing ALN-AGT01 RVR for mild to moderate high blood pressure
This study tests a new experimental drug called ALN-AGT01 RVR in people with mild to moderate high blood pressure. The drug may help lower blood pressure by targeting a protein in the body that regulates blood pressure.
Lake Forest, CaliforniaAges 18–75 - NCT07559396RecruitingPhase 1
Safety study of INCB123667 in adults with severe kidney disease
This study tests how a new experimental drug (INCB123667) works and is tolerated in adults with severe kidney problems or end-stage kidney disease. Researchers want to understand how the drug moves through the body and whether it's safe for people in your situation.
Miami Lakes, FloridaAges 18–85 - NCT07556458Recruiting
Testosterone supplement study for adult men with low levels
This study tests a dietary supplement designed to raise testosterone levels in men who have low testosterone. If you qualify, you'll take the supplement and provide blood samples to see if your levels increase.
Carlsbad, CaliforniaAges 28–65 - NCT07554469Recruiting
Study of Finerenone for Kidney Disease in Type 2 Diabetes
This observational study tracks how well finerenone (a kidney-protective medication) works in adults with type 2 diabetes and chronic kidney disease in Spain. Researchers will measure changes in kidney function and disease risk over time to better understand the medication's real-world benefits.
Many LocationsAges 18 years+ - NCT07559474RecruitingPhase 1
Safety Study of INCB123667 in Adults With Liver Damage
This study tests how a new experimental medicine (INCB123667) works and is tolerated in adults with moderate to severe liver problems. Researchers want to understand how the body processes this drug and whether it's safe in people with liver dysfunction.
Chandler, ArizonaAges 18–80 - NCT07557420RecruitingPhase 3
Ravulizumab for Neuromyelitis Optica Spectrum Disorder in Chinese Adults
This study tests a new medicine called ravulizumab (an infusion) to reduce relapses in people with neuromyelitis optica spectrum disorder (NMOSD), a rare condition affecting the optic nerve and spinal cord. The trial is specifically enrolling adults in China who have had recent disease activity.
BeijingAges 18–130 - NCT06742580Recruiting
Sudden facial paralysis and homocysteine study
This study looks at a possible link between a substance in the blood called homocysteine and sudden facial paralysis (Bell's palsy). If you've recently been diagnosed with this condition, you may be able to join.
AfyonkarahisarAges 18–80 - NCT06742112Recruiting
Arm and Breathing Test for People Who Are Overweight
This study looks at how well people who are overweight or obese can use their arms and breathe while performing a 6-minute pegboard and ring test. Researchers want to see if this test can help measure physical function in this group.
KırşehirAges 18–65 - NCT04654650Recruiting
Study of adults with pulmonary hypertension for long-term data
This study follows adults with pulmonary hypertension over the long term and collects information (and possibly samples) to better understand how the condition changes over time. It may help researchers learn what factors affect outcomes, which can improve care in the future.
Hamburg, Free and Hanseatic City of HamburgAges 18 years+ - NCT07543055RecruitingPhase 1
CAR T-Cell Therapy for Advanced Prostate Cancer
This trial tests BPX-601, a new type of cell therapy that uses your own immune cells to fight prostate cancer that has spread and stopped responding to hormone treatments. The study aims to see if this approach can help men whose cancer has returned despite multiple prior treatments.
Atlanta, GeorgiaAges 18 years+ - NCT07547813RecruitingPhase 2
Testing LAD328 for moderate-to-severe hidradenitis suppurativa
This study tests a new drug called LAD328 for hidradenitis suppurativa (HS), a chronic skin condition with painful lumps and abscesses. The trial is looking for adults with moderate-to-severe HS who haven't responded well to antibiotics to see if this new treatment can help reduce symptoms.
Warsaw, Masovian VoivodeshipAges 18–65 - NCT07543419Recruiting
Real-world Study of Secukinumab for Moderate to Severe Hidradenitis Suppurativa
This study tracks how secukinumab (a new medication) works for hidradenitis suppurativa—a painful skin condition with recurring boils and abscesses—in real-world patient care in Italy. Researchers want to understand treatment patterns and outcomes to help improve care for this condition.
Ancona, ANAges 18–100 - NCT07546812RecruitingPhase 2
Testing Denikitug for advanced stomach and esophageal cancer
This study tests a new drug called denikitug, alone or combined with other cancer treatments, for patients with advanced stomach, gastroesophageal junction, or esophageal adenocarcinoma that has progressed after initial treatment. The drug targets immune cells to help your body fight cancer.
Boston, MassachusettsAges 18 years+ - NCT07549919RecruitingPhase 1
Food Effects on a New Experimental Drug in Healthy Men
This study tests how food affects how the body absorbs and processes a new experimental drug called AJ201. Researchers will give the drug to healthy men with and without food to see if it makes a difference, and they'll check for any side effects.
Los Alamitos, CaliforniaAges 18–55 - NCT06323889Recruiting
Intermittent fasting study for adults with obesity
This study tests whether intermittent fasting (alternating periods of eating and fasting) can help with weight loss and health in adults with obesity. It aims to see if this approach is safe and effective.
Zurich, Canton of ZurichAges 18–50 - NCT07543653Recruiting
Testing ways to reduce loneliness in young Chinese adults
This study tests different approaches to help young adults (ages 18–30) who feel lonely. Researchers want to see which methods work best to help people feel more connected.
Hong Kong, Hong KongAges 18–30 - NCT07546409Recruiting
Do ketones help thinking in older adults with prediabetes?
This study looks at whether a supplement called ketones can improve thinking and memory in older adults who have prediabetes but not diabetes or memory problems. You will take the supplement, have brain scans, and complete thinking tests.
Birmingham, AlabamaAges 60–75 - NCT07545915Recruiting
Web-based group program supporting healthy aging
This trial tests an online group program designed to help people 65 and older stay socially connected and healthy after retirement or major life changes. You'll join video meetings with others and learn ways to maintain well-being.
LuleåAges 65 years+
Hear when a new Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adult?
- Yes. Clin2 currently lists 3,745 recruiting adult studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adult trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adult trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.